Abacus Diagnostica offers rapid and easy-to-use solutions for COVID-19 diagnostics. The SARS-CoV-2 assay portfolio consists of two CE-marked tests, the SARS-CoV-2 Assay and the SARS-CoV-2, Flu A/B + RSV Assay, for the automated GenomEra® CDX system. Additionally, Abacus has a research use test for detection of the SARS-CoV-2 Variants of Concern strains. The tests are used by laboratories in 20+ countries, including the majority of university and central hospital laboratories in Finland. (Updated in June 2021)
ArcDia International provides CE marked products for rapid antigen testing of COVID-19. The mariPOC® COVID-19 tests are widely used globally in decentralised testing and laboratory testing as well as in occupational surveillance. In the spring of 2021, the company launched a range of exceptionally sensitive point-of-care rapid tests for COVID-19. (Updated in June 2021)
Ginolis provides automated manufacturing equipment for the production and processing of diagnostic devices, such as rapid tests, point-of-care, microfluidic devices, diagnostics, test cartridges and IVD tests. The company helps its customers to ensure the continuity of COVID-19 test manufacturing.
iSTOC is offering a high-end mobile application capturing data from rapid diagnostic tests, and secure cloud service and analytics platform. This enables a versatile management of disease surveillance and patient data with instant feedback to the user. iSTOC service can be utilised by governments, NGOs, corporates and private sector entities in crisis management, for example related to COVID-19 pandemic both in screening of general population and identifying infected individuals, and issuing “COVID-19 passports”. (Updated in June 2021)
Mobidiag develops and markets molecular diagnostics for Gastrointestinal, Healthcare Associated and Respiratory Infections, as well as Antimicrobial Resistance Management. The company aims at providing a global solution to clinicians suited for their own laboratory needs and capacities. During the COVID-19 crisis, Mobidiag has harnessed their existing technologies to rapidly provide coronavirus diagnostic tests based on proprietary platforms Amplidiag® Easy (for batch testing) and Novodiag® (for on-demand testing). (Updated in June 2021)
Salofa manufactures a COVID-19 rapid test that also detects asymptomatic carriers. The tests are for professional use.
Tezted has developed SARSPLEX, a unique multiplex antibody test that measures IgM, IgG, and IgA immune responses to the SARS-CoV-2 virus. The test is an enzyme linked immunosorbent assay (ELISA) that is CE and IVD marked for professional use only.
Etsimo’s CE-marked medical device is an AI driven solution based on demographic information, symptoms and risk factors and it helps in guiding patients to the right care at the right time with the right information. The company’s COVID-19 version is being built on the same technology. The solution is able to give probabilities on COVID-19 and other respiratory infections. This means that it is able to grade suspicions of the virus and also estimate other possible reasons, i.e. diseases for the symptoms. This provides peace of mind to the consumer while giving the opportunity to triage them to non-COVID-19 care and thus offloading coronavirus related services. Triaging is personalised and consumers can be segmented and directed into right care paths. Etsimo’s solution is helping healthcare in Brazil to cope with COVID-19.
Innokas Medical offers COVID-19 analysis of patients: symptom description, disease tracing, comparison with Swedish and US care organisations. The company also provides care-at-home allowing monitored care for coronavirus risk groups.